Latest Financial Results
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2021
Sign up today and receive company updates straight to your inbox.Sign up today
We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Our secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with physician/medical providers to administer intravenous infusions of ketamine.
Pasithea Therapeutics Corp.
1111 Lincoln Road
Miami Beach, FL 33139
In-Site Communications, Inc
VStock Transfer, LLC
Pasquale Preziosa Jr
Director of On-Boarding and Corporate Actions
18 Lafayette Place
Woodmere, New York 11598